Literature DB >> 6641787

Rheumatoid factors and secondary immune responses in the mouse. II. Incidence, kinetics and induction mechanisms.

P Coulie, J Van Snick.   

Abstract

Production of IgM rheumatoid factor (RF) during secondary immune responses was studied in normal mouse strains by measuring RF synthesis in spleen cell cultures. A considerable, although transient, RF response was observed in BALB/c and C57BL/6 mice immunized and i.v. boosted with various protein antigens and with sheep erythrocytes. With most antigens, RF production equalled or exceeded that of antigen-specific IgM, but it peaked and subsided earlier. No RF production was detected when either priming or boosting was omitted. The isotypic specificity of RF depended upon the antigens used for immunization: all proteins tested stimulated the synthesis of RF specific for IgG1, whereas sheep erythrocytes induced both IgG1- and IgG2a-specific RF. Reconstitution experiments of irradiated naïve C57BL/6 mice with various combinations of syngeneic antibody against human transferrin and primed or unprimed spleen cells indicated that important RF responses could be induced only when antigen was injected into mice that had received both antibody and immune spleen cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6641787     DOI: 10.1002/eji.1830131107

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  26 in total

1.  Diversification of the Ig variable region gene repertoire of synovial B lymphocytes by nucleotide insertion and deletion.

Authors:  Yasushi Miura; Charles C Chu; David M Dines; Stanley E Asnis; Richard A Furie; Nicholas Chiorazzi
Journal:  Mol Med       Date:  2003 May-Aug       Impact factor: 6.354

2.  Functional affinity of IgM rheumatoid factor in patients with rheumatoid arthritis and other autoimmune diseases.

Authors:  S Rath; D N Hogben; M E Devey
Journal:  Ann Rheum Dis       Date:  1988-04       Impact factor: 19.103

3.  Genetic basis for the cross-reactive idiotypes on the light chains of human IgM anti-IgG autoantibodies.

Authors:  P P Chen; K Albrandt; N K Orida; V Radoux; E Y Chen; R Schrantz; F T Liu; D A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

Review 4.  T lymphocytes in synovia of patients with rheumatoid arthritis.

Authors:  I Stamenkovic; M Stegagno; S M Krane; J T Kurnick
Journal:  Springer Semin Immunopathol       Date:  1988

5.  Experimental induction of rheumatoid factor and joint lesions in rabbits after intravenous injections of killed bacteria.

Authors:  A C Hanglow; C J Welsh; P Conn; J M Pitts; A Rampling; R R Coombs
Journal:  Ann Rheum Dis       Date:  1986-01       Impact factor: 19.103

6.  Cloning and sequence determination of a human rheumatoid factor light-chain gene.

Authors:  F R Jirik; J Sorge; S Fong; J G Heitzmann; J G Curd; P P Chen; R Goldfien; D A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

7.  Studies on rheumatoid factor: I. The effect of rheumatoid factor on the clearance of preformed immune complexes in mice.

Authors:  D N Hogben; M E Devey
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

8.  Spontaneous in vitro production of rheumatoid factor during infectious exacerbations of cystic fibrosis: correlation with circulating immune complex levels.

Authors:  M T Keogan; M Callaghan; G Yanni; D Mulherin; C Feighery; D L Brown; M X Fitzgerald; B Bresnihan
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

9.  Activation of effector functions by immune complexes of mouse IgG2a with isotype-specific autoantibodies.

Authors:  E Rajnavölgyi; G Fazekas; J Lund; M Daeron; J L Teillaud; R Jefferis; W H Fridman; J Gergely
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

10.  Rheumatoid factors from the peripheral blood of two patients with rheumatoid arthritis are genetically heterogeneous and somatically mutated.

Authors:  K Youngblood; L Fruchter; G Ding; J Lopez; V Bonagura; A Davidson
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.